Delivery Order SPE2DB20D2014-SPE2DB24FC05F
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET UD 60S, a pharmaceutical product, with a ceiling value of $2,319.42 and a period of performance through May 9, 2025. This contract is not set-aside and is a firm fixed-price, delivery order contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $1,678.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of May 16, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VIMPAT 200 MG TABLET 60S, a pharmaceutical product. The $2,501.60 firm-fixed-price contract has a completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medication tablets under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.46 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,117.65 firm fixed-price contract is for the supply of VIMPAT 50 mg tablets. This order is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs and facilities worldwide. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,313.39, is for the delivery of VIMPAT 200 MG TABLET UD 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET 60S, a prescription medication, with a ceiling value of $3,318.54 and a completion date of August 8, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating it was awarded...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET UD 60S, a medication, with a ceiling value of $1,071.27. The contract is a Firm Fixed Price (FFP) delivery order and is not set aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VIMPAT 200 mg Tablet 60s, a pharmaceutical product. The contract has a ceiling value of $2,906.80 and a period of performance through August 1, 2024. It is a firm-fixed-price contract and was not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide the required medication to support military treatment facilities...
- This federal contract award, valued at $1,759.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the government. The contract has a completion date of May 7, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FC05FDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,662.19, is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of May 30, 2024 and is a firm fixed-price, delivery order type contract. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 5/29/24 |